?? Event alert from Wharton Biotech Conference organized by Penn Biotech Group
The Wharton Biotech Conference 2025, organized by Penn Biotech Group, is bringing together top industry leaders, entrepreneurs, investors, and regulatory experts to explore the evolving biotech landscape. Meet our featured panelists and moderators for our second Panelist Spotlight: ?? Adam Runkle – Associate Director Regulatory Affairs at Daiichi Sankyo; Owner of keV Pharma Consulting, LLC ?? Scott Greenfeder – Vice President, Head Regulatory Affairs Oncology Nucleus at Bayer | Pharmaceuticals ?? Heather A. Steinman, PhD, MBA – SVP, Business Development & Executive Director, Technology Transfer at The Wistar Institute ?? Michael Kalos – Managing Director, Next Pillar Consulting | Senior Venture Partner, Orange Grove Bio | CEO, IpiNovyx ?? Joshua Reynolds – Founder and CEO, Atlas Biotech ?? Hongbo Z. – Venture Capitalist, Gaorong Ventures These experts will share invaluable insights on entrepreneurship, commercialization, regulatory strategy, and more. ?? Join us on April 26, 2025, at The Wharton School! ?? Learn more: https://lnkd.in/dNSRybY3 ??? Early bird registration opens soon! Penn graduate students get exclusive discounts. More announcements to come – stay tuned! #WhartonBiotechConference #WBC2025 #BiotechLeadership #LifeSciences #HealthcareInnovation #Investment #RegulatoryAffairs Penn Biotech Group GAPSA - University of Pennsylvania
